The role of SATB1 in breast cancer pathogenesis

Journal of the National Cancer Institute

Volumn 102, Issue 16, 2010, Pages 1284-1296

  Iorns, Elizabeth ^a   Hnatyszyn, H James ^a   Seo, Pearl ^a   Clarke, Jennifer ^a   Ward, Toby ^a   Lippman, Marc ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIGEL; MESSENGER RNA; ONCOPROTEIN; PROTEIN SATB1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER MODEL; CANCER PATIENT; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS; MICROARRAY ANALYSIS; MORPHOLOGY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR XENOGRAFT; WOUND HEALING;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; COLLAGEN; DRUG COMBINATIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; LAMININ; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICE; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; WOUND HEALING;

EID: 77955959658     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq243     Document Type: Article

References (33)

1. Han HJ, Russo J, Kohwi Y, et al. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature. 2008; 452 (7184): 187-193.
2. Purbey PK, Singh S, Notani D, et al. Acetylation-dependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1. Mol Cell Biol. 2009; 29 (5): 1321-1337.
3. Yasui D, Miyano M, Cai S, et al. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature. 2002; 419 (6907): 641-645.
4. Dickinson LA, Joh T, Kohwi Y, et al. A tissue-specifi c MAR/SAR DNA-binding protein with unusual binding site recognition. Cell. 1992; 70 (4): 631-645.
5. Cai S, Han HJ, Kohwi-Shigematsu T. Tissue-specifi c nuclear architecture and gene expression regulated by SATB1. Nat Genet. 2003; 34 (1): 42-51.
6. Cai S, Lee CC, Kohwi-Shigematsu T. SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet. 2006; 38 (11): 1278-1288.
7. Kumar PP, Bischof O, Purbey PK, et al. Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol. 2007; 9 (1): 45-56.
8. Lee J, Klase Z, Gao X, et al. Cellular homeoproteins, SATB1 and CDP, bind to the unique region between the human cytomegalovirus UL127 and major immediate-early genes. Virology. 2007; 366 (1): 117-125.
9. Sun Y, Wang T, Su Y, et al. The behavior of SATB1, a MAR-binding protein, in response to apoptosis stimulation. Cell Biol Int. 2006; 30 (3): 244-247.
10. Galande S, Dickinson LA, Mian IS, et al. SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis. Mol Cell Biol. 2001; 21 (16): 5591-5604.
11. Purbey PK, Singh S, Kumar PP, et al. PDZ domain-mediated dimeriza-tion and homeodomain-directed specifi city are required for high-affi nity DNA binding by SATB1. Nucleic Acids Res. 2008; 36 (7): 2107-2122.
12. Kumar PP, Purbey PK, Ravi DS, et al. Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodefi ciency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. Mol Cell Biol. 2005; 25 (5): 1620-1633.
13. Pavan Kumar P, Purbey PK, Sinha CK, et al. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcrip-tional activity in vivo. Mol Cell. 2006; 22 (2): 231-243.
14. Ince TA, Richardson AL, Bell GW, et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell. 2007; 12 (2): 160-170.
15. Dunning MJ, Smith ML, Ritchie ME, et al. beadarray: R classes and methods for Illumina bead-based data. Bioinformatics. 2007; 23 (16): 2183-2184.
16. Team RDC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. 2008: 1-1731.
17. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3 (1): Article3.
18. Bild AH, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006; 439 (7074): 353-357.
19. Chin K, DeVries S, Fridlyand J, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006; 10 (6): 529-541.
20. Desmedt C, Piette F, Loi S, et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res. 2007; 13 (11): 3207-3214.
21. Miller LD, Smeds J, George J, et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci\USA. 2005; 102 (38): 13550-13555.
22. Pawitan Y, Bjöhle J, Amler L, et al. Gene expression profi ling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005; 7 (6): R953-R964.
23. Wang Y, Klijn JG, Zhang Y, et al. Gene-expression profi les to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005; 365 (9460): 671-679.
24. Hastie T, Tibshirani R, Narasimhan B, et al. pamr: Prediction Analysis for Microarrays. R package (version 1.42.0). Vienna, Austria: R Foundation for Statistical Computing. 2009.
25. Therneau T. survival: Survival Analysis, Including Penalized Likelihood. R package (version 2.35-4). R Foundation for Statistical Computing 2009.
26. Lumley T. rmeta: Meta-analysis. R package (version 2.15). R Foundation for Statistical Computing. 2009.
27. Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006; 10 (6): 515-527.
28. Hoefl ich KP, O'Brien C, Boyd Z, et al. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Clin Cancer Res. 2009; 15 (14): 4649-4664.
29. Huang F, Reeves K, Han X, et al. Identifi cation of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection. Cancer Res. 2007; 67 (5): 2226-2238.
30. Patani N, Jiang W, Mansel R, et al. The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int. 2009; 9 (18): 1-10.
31. Li K, Cai R, Dai BB, et al. SATB1 regulates SPARC expression in K562 cell line through binding to a specifi c sequence in the third intron. Biochem Biophys Res Commun. 2007; 356 (1): 6-12.
32. Agrelo R, Souabni A, Novatchkova M, et al. SATB1 defi nes the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell. 2009; 16 (4): 507-516.
33. Steidl U, Steidl C, Ebralidze A, et al. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. J Clin Invest. 2007; 117 (9): 2611-2620.